Effect of COVID-19 on hepatitis B and C virus countermeasures: Hepatologist responses from nationwide survey in Japan.
COVID-19
HBV
HCV
Japan
effect
response
Journal
Hepatology research : the official journal of the Japan Society of Hepatology
ISSN: 1386-6346
Titre abrégé: Hepatol Res
Pays: Netherlands
ID NLM: 9711801
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
15
07
2022
received:
12
05
2022
accepted:
17
07
2022
pubmed:
22
7
2022
medline:
22
7
2022
entrez:
21
7
2022
Statut:
ppublish
Résumé
Achieving hepatitis B virus (HBV) and hepatitis C virus (HCV) elimination requires continuous and sustained high volumes of diagnosis and treatment, which have been affected by the ongoing COVID-19 pandemic. This study assessed the effects of COVID-19 on hepatitis-related services in Japan and compared Japan's situation with a global survey. We conducted an online cross-sectional questionnaire survey of hepatologists from the Japan Society of Hepatology from August to October 2021 by using the same questionnaire from which a survey was conducted globally to address the effects of COVID-19 on hepatitis-related services. Hepatologists responded based on own impressions of their affiliated institutions. In total, 196 hepatologists participated from 35 prefectures including 49.5% in managerial positions. Approximately 40% survey participants reported a 1%-25% decline in HBV and HCV screening and confirmatory testing. In addition, 53.6% and 45.4% reported no decline in HBV and HCV treatment initiation, respectively. Comparing any level of decrease with the global survey, there was less of a decline observed in Japan for screening (HBV: 51% vs. 56.3%, HCV: 51% vs. 70.9%) and treatment initiation (HBV: 32.7% vs. 52.4%, HCV: 41.8% vs. 66%). However, patient anxiety/fear (67.4%) and loss of staff due to COVID-19 (49.0%) were reported as challenges for resuming services to pre-COVID-19 levels. Although in Japan all-inclusive decline in HBV- and HCV-related services were lower than in other countries, a greater decline was observed in HBV and HCV screening and diagnosis than in treatment initiation. Prolonged anxiety/fear among patients, and loss of staff and facilities from the COVID-19 response activities must be addressed to achieve elimination of hepatitis by 2030.
Identifiants
pubmed: 35861597
doi: 10.1111/hepr.13819
pmc: PMC9349947
doi:
Types de publication
Journal Article
Langues
eng
Pagination
899-907Subventions
Organisme : Japan Ministry of Health, Labour and Welfare
ID : 19HC1001
Informations de copyright
© 2022 The Authors. Hepatology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Hepatology.
Références
World Health Organization. Global health sectors strategy on Viral Hepatitis 2016-2021; 2016.
World Health Organization. Global hepatitis report. 2017 21 April. Geneva: WHO; 2017.
Tanaka J, Akita T, Ko K, Miura Y, Satake M. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res. 2019;49(9):990-1002. https://doi.org/10.1111/hepr.13417
Ministry of Health LaW, Japan. Basic act on hepatitis measure; 2011.
Kanto T. Messages from Japan policy for viral hepatitis. Global Health Med. 2021;3(5):249-52. https://doi.org/10.35772/ghm.2021.01078
Tanaka J, Akita T, Ohisa M, Sakamune K, Ko K, Uchida S, et al. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J Viral Hepat. 2018;25(4):363-72. https://doi.org/10.1111/jvh.12828
Takeuchi Y, Ohara M, Kanto T. Nationwide awareness-raising program for viral hepatitis in Japan: the “Shitte kan-en” project. Global Health Med. 2021;3(5):301-7. https://doi.org/10.35772/ghm.2021.01063
Ministry of Health LaW, Japan. Basic guidelines for promotion of control measures for hepatitis; 2016.
Tanaka J, Kurisu A, Ohara M, Ouoba S, Ohisa M, Sugiyama A, et al. Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study. Lancet Reg Health Western Pac 2022;22:100428. https://doi.org/10.1016/j.lanwpc.2022.100428
Ko K, Akita T, Satake M, Tanaka J. Epidemiology of viral hepatitis C: road to elimination in Japan. Global Health med. 2021;3(5):262-9. https://doi.org/10.35772/ghm.2021.01069
Collaborators PO. The case for simplifying and using absolute targets for viral hepatitis elimination goals. J Viral Hepatitis. 2021;28(1):12-9.
Center for Infectious Disease Research and Policy (CIDRAP) UoM. Chinese officials probe unidentified pneumonia outbreak in Wuhan: Center for Infectious Disease Research and Policy. University of Minnesota; 2019. https://www.cidrap.umn.edu/news-perspective/2019/12/news-scan-dec-31-2019
WHO. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 2020 [updated 11 March]. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
WHO. Novel Coronavirus (2019-nCoV) SITUATION REPORT - 1. 2021.
Blumenthal D, Fowler EJ, Abrams M, Collins SR. Covid-19 - implications for the health care system. N Engl J Med. 2020;383(15):1483-8. https://doi.org/10.1056/nejmsb2021088
Poudel AN, Zhu S, Cooper N, Roderick P, Alwan N, Tarrant C, et al. Impact of Covid-19 on health-related quality of life of patients: a structured review. PLoS One. 2021;16(10):e0259164. https://doi.org/10.1371/journal.pone.0259164
Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3):e045343. https://doi.org/10.1136/bmjopen-2020-045343
Pley CM, McNaughton AL, Matthews PC, Lourenço J. The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. BMJ Global Health. 2021;6(1):e004275. https://doi.org/10.1136/bmjgh-2020-004275
Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, et al. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2021;74(1):31-6. https://doi.org/10.1016/j.jhep.2020.07.042
Sonneveld MJ, Veldhuijzen IK, van de Laar TJW, Op de Coul ELM, van der Meer AJ. Decrease in viral hepatitis diagnoses during the COVID-19 pandemic in the Netherlands. J Hepatol. 2021. https://doi.org/10.1016/j.jhep.2021.04.015
Mandel E, Peci A, Cronin K, Capraru CI, Shah H, Janssen HLA, et al. The impact of the first, second and third waves of Covid-19 on hepatitis B and C testing in Ontario, Canada. J Viral Hepat. 2022;29(3):205-8. https://doi.org/10.1111/jvh.13637
Laury J, Hiebert L, Ward JW. Impact of COVID-19 response on hepatitis prevention care and treatment: results from global survey of providers and program managers. Clin Liver Dis. 2021;17(1):41-6. https://doi.org/10.1002/cld.1088
Kondo R, Kawaguchi N, McConnell MJ, Sonzogni A, Licini L, Valle C, et al. Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients: a series of 43 cases. Hepatol Res. 2021;51(9):1000-6. https://doi.org/10.1111/hepr.13696
Kudo M, Kurosaki M, Ikeda M, Aikata H, Hiraoka A, Torimura T, et al. Treatment of hepatocellular carcinoma during the COVID-19 outbreak: the Working Group report of JAMTT-HCC. Hepatol Res. 2020;50(9):1004-14. https://doi.org/10.1111/hepr.13541
Suda G, Ogawa K, Kimura M, Maehara O, Kitagataya T, Ohara M, et al. Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19. Hepatol Res. 2020;50(10):1196-200. https://doi.org/10.1111/hepr.13551
Tsutsumi T, Saito M, Nagai H, Yamamoto S, Ikeuchi K, Lim LA, et al. Association of coagulopathy with liver dysfunction in patients with COVID-19. Hepatol Res. 2021;51(2):227-32. https://doi.org/10.1111/hepr.13577
Ito J, Edirippulige S, Aono T, Armfield NR. The use of telemedicine for delivering healthcare in Japan: systematic review of literature published in Japanese and English languages. J Telemed Telecare. 2017;23(10):828-34. https://doi.org/10.1177/1357633x17732801
Golinelli D, Boetto E, Carullo G, Nuzzolese AG, Landini MP, Fantini MP. Adoption of digital technologies in health care during the COVID-19 pandemic: systematic review of early scientific literature. J Med Internet Res. 2020;22(11):e22280. https://doi.org/10.2196/22280
Ministry of Health LaW, Japan. COVID-19 situation in Japan 2022. https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou_00006.html
FOUNDATION MI. COVID-19 in Africa, one year on: impact and prospect. Angola; 2021.
Waheed Y. Progress on global hepatitis elimination targets. World J Gastroenterol. 2021;27(47):8199-200. https://doi.org/10.3748/wjg.v27.i47.8199